Presentations
Important:
These original OMOP resources are no longer supported. You can find the latest developments by visiting the OHDSI presentations website.
|
OMOP Presentations |
Download |
Real World Evidence and Pharmaceuticals by Christian Reich |
October 16, 2013 |
|
An Empirical Approach to Measuring and Calibrating for Error in Observational Analyses by Patrick Ryan |
September 26, 2013 |
|
29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), Montréal, Canada, August 2013. |
Click on each individual presentation to download |
|
Perspectives on Data Quality Assessment by Patrick Ryan |
June 23, 2013 |
|
How the OMOP Common Data Model Enables Standardized Analytics by Patrick Ryan |
June 22, 2013 |
|
Empirical learning from observational analyses: OMOP Lessons by Patrick Ryan |
June 12, 2013 |
|
Analysis of Longitudinal Databases by Patrick Ryan |
June 11, 2013 |
|
IMEDS Overview by Troy McCall |
June 6, 2013 YouTube video |
|
OMOP Research Results by William DuMouchel |
May 21, 2013 |
|
Challenges of Analyzing OMOP Results and Some Visual Approaches, by Rebecca Ferrell, University of Washington |
May 9, 2013 |
|
Analysis of the OMOP Results Database: Does the Method Matter More than the Truth? by Alan F. Karr |
April 26, 2013 |
|
An Empirical Approach to Measuring and Calibrating for Error in Observational Analyses by Patrick Ryan |
April 25, 2013 |
|
Cross Industry Data Partnerships and OMOP by Christian Reich |
April 8, 2013 |
|
OMOP Common Data Model, SAFTINet and ROSITA by Lisa Schilling |
March 22, 2013 |
|
Perspectives on Data Quality Assessment: OMOP Lessons Learned by Patrick Ryan |
March 22, 2013 |
|
Advancing the Science of a Risk Identification System: Research Findings from OMOP by Abraham Hartzema and Patrick Ryan |
October 23, 2012 |
|
Lessons from the Observational Medical Outcomes Partnership: Opportunities for Exploring Healthcare Databases to Study the Effects of Medical Products by Patrick Ryan |
August 29, 2012 |
|
Highlights from the OMOP 2012 Annual Symposium presented by Patrick Ryan and Martijn Schuemie |
August 8, 2012 |
|
Active surveillance on medical observational databases presented by Ivan Zorych |
August 2, 2012 |
|
2012 OMOP Symposium presentations and audio |
June 28, 2012 |
|
Opportunities for Leveraging National Surveillance Research Efforts to Improve Industry Pharmacovigilance Operations by Patrick Ryan |
June 27, 2012 |
|
Opportunities for a Risk Identification System: Lessons from the Observational Medical Outcomes Partnership by Patrick Ryan |
June 26, 2012 |
|
Beyond relative risk: A drug safety framework for exploring causal effects in observational data presented by Patrick Ryan |
May 24, 2012 |
|
Patient-centered observational analytics: New directions toward studying effects of medical products presented by Patrick Ryan |
May 22, 2012 |
|
Beyond relative risk: A drug safety framework for exploring causal effects in observational data presented by Patrick Ryan |
April 24, 2012 |
|
Opportunities for exploratory visualization in observational data analytics presented by Patrick Ryan |
April 23, 2012 |
|
Informatics opportunities in exploring electronic health records: Lessons from the Observational Medical Outcomes Partnership presented by Patrick Ryan |
February 29, 2012 |
|
Create Value from Data, Governance, Ethics and Appropriate Use presented by Thomas Scarnecchia |
February 20, 2012 |
|
Statistical Methods for Drug Safety Surveillance by David Madigan |
December 7, 2011 |
|
Introduction to the OMOP Common Data Model Version 3.0 presented by Patrick Ryan and Lisa Schilling |
December 2, 2011 Slides Watch the Presentation on the OMOP site |
|
New Paradigms in Clinical Trial Methodology Symposium by David Madigan |
November 17, 2011 |
|
HIMSS Life Sciences Roundtable - Advancing the Science of Observational Data Analysis in Life Science by Marc Overhage |
November 16, 2011
Slides only Audio / Slides |
|
AcademyHealth Electronic Data Methods Forum Symposium- Opportunities for Standardized Observational Analytics to Support Causal Inference in Comparative Effectiveness Research by Patrick Ryan |
October 27, 2011 |
|
AMIA 2011 Annual Symposium - Design and Validation of a Data-simulation Model for Longitudinal Healthcare Data by Rich Murray and Patrick Ryan |
October 26, 2011 |
|
Query Health - “Summer Concert Series" on Distributed Population Queries. The Observational Medical Outcomes |
August 29, 2011 |
|
32nd Annual Conference of the International Society for Clinical Biostatistics (ISCB); Ottawa, Canada. Empirical Performance of Large-scale Analysis Methods for Active Surveillance: Lessons from the OMOP presented by Patrick Ryan |
August 25, 2011 |
|
ISPE 2011, 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. "Drug Induced Liver Injury: Latest Developments on Premarket Regulatory Guidance and Approaches to Postmarket Surveillance presented by Judy Racoosin |
August 16, 2011 |
|
ISPE 2011, 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. "Methods Development in Active Drug Safety Surveillance Highlighting the OMOP Findings presented by Abraham Hartzema, Patrick Ryan and Paul Stang |
|
|
2011 Joint Statistical Meetings. Bayesian Logistic Regression For Medical Claims Data Using CPU And GPU presented by Ivan Zorych |
|
|
DIA 2011 Annual Meeting. OMOP: Overview of Experimental Results presented by David Madigan |
|
|
Drug Safety Research Unit (DSRU) 6th Biennial Conference - Signal Detection and Interpretation in Pharmacovigilance, London, UK, presented by Patrick Ryan and David Madigan - June 2011 |
Click on each individual presentation to download |
|
OMOP Poster at the 3rd DEcIDE Methods Symposium 2011: Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research. OMOP Poster: An Empiric Exploration of Analytical Methods and Outcome Definitions for Patient Centered Outcomes Research |
FDA/PhRMA Biostatistics, Data Management, Scientific Programming Leaders Meeting, FDA, Rockville, MD |
Click on each individual presentation to download |
|
AcademyHealth, Electronic Data Methods Forum Symposium, Washington, DC: OMOP Results and Highlights presented by David Madigan |
|
|
International Society for Pharmacoepidemiology (ISPE) 2011 Mid-Year Meeting: OMOP Results and Perspectives presented by Patrick Ryan |
|
|
Brookings Roundtable: Highlights from the OMOP Symposium presented by Patrick Ryan |
|
|
Post-Market Safety Session of the 2nd Annual FDA / DIA Computational Science Meeting, Washington DC, Active Surveillance Methods Performance and Challenges: Lessons from OMOP presented by Patrick Ryan |
|
|
Pharmacovigilance and Risk Management Strategies 2011- DIA panel: Analysis for Health Care Data presented by Jonathan Morris, MD (UnitedBioSource) |
|
|
Pharmacovigilance and Risk Management Strategies 2011- DIA panel: Analysis for Health Care Data presented by Thomas Scarnecchia |
|
|
PRISM Forum Special Interest Group 2010 - Informatics Opportunities for Exploring the Real-World Effects of Medical Products: Lessons from the Observational Medical Outcomes Partnership presented by Patrick Ryan |
|
|
The Spotfire Life Science Forum 2010 - Visualization opportunities for systematic analyses of observational healthcare data: lessons from the Observational Medical Outcomes Partnership presented by Patrick Ryan |
|
|
Brookings Event - Methods for Signal Refinement in Active Medical Product Surveillance |
|
|
26th ICPE: International Conference on Pharmacoepidemiology & Therapeutic Risk Management - Implementing & Evaluating Standard Cohort Definitions, Steph Reisinger and Patrick Ryan |
|
|
OMOP Method Evaluation Discussion presented to the FDA by David Madigan and Patrick Ryan |
|
|
2010 Joint Statistical Meeting - The Role of Statistics and Opportunities for Statisticians in Active Drug Safety Surveillance presented by Patrick Ryan |
|
|
2010 Joint Statistical Meeting - OMOP Methods Development presented by David Madigan |
|
|
WorldPharma 2010 - OMOP Methods Overview & Insights presented by Abraham G. Hartzema |
|
|
Brookings Roundtable on Active Medical Product Surveillance - OMOP Methods Overview & Progress presented by David Madigan & Patrick Ryan |
|
|
46th Annual DIA Meeting 2010 - The Role of Statistics & Opportunities for Statisticians in Active Drug Safety Surveillance presented by Patrick Ryan |
|
|
46th Annual DIA Meeting 2010 - OMOP Overview & Progress presented by |
|
|
OMOP Extended Consortium Overview presented by Patrick Ryan |
|
|
ISPE Mid-Year Symposium - April 12, 2010 |
Click on each individual presentation to download |
|
OMOP: Overview of Methods Development and Evaluation Overview & Progress presented at the FDA |
|
|
OMOP Overview & Progress presented at the FDA |
|
|
DIA Conference on Signal Detection & Data Mining |
|
|
M2009 Data Mining Conference |
|
|
Institute of Medicine of the National Academies |
|
|
DIA Annual Meeting |
|
|
Midwest Biopharmaceutical Statistics Workshop |